Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

2 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Dynamics of myeloid cell populations during relapse-preventive immunotherapy in acute myeloid leukemia.
Rydström A, Hallner A, Aurelius J, Sander FE, Bernson E, Kiffin R, Thoren FB, Hellstrand K, Martner A. Rydström A, et al. J Leukoc Biol. 2017 Aug;102(2):467-474. doi: 10.1189/jlb.5VMA1116-455R. Epub 2017 Feb 24. J Leukoc Biol. 2017. PMID: 28235771 Clinical Trial.
Relapse of leukemia in the postchemotherapy phase contributes to the poor prognosis and survival in patients with acute myeloid leukemia (AML). ...These results suggest that aspects of myeloid cell biology may impact clinical benef
Relapse of leukemia in the postchemotherapy phase contributes to the poor prognosis and survival in patients with acute
Circulating CD14(+) HLA-DR(-/low) myeloid-derived suppressor cells in leukemia patients with allogeneic hematopoietic stem cell transplantation: novel clinical potential strategies for the prevention and cellular therapy of graft-versus-host disease.
Yin J, Wang C, Huang M, Mao X, Zhou J, Zhang Y. Yin J, et al. Cancer Med. 2016 Jul;5(7):1654-69. doi: 10.1002/cam4.688. Epub 2016 Apr 25. Cancer Med. 2016. PMID: 27109254 Free PMC article.
Myeloid-derived suppressor cells (MDSCs) are a heterogeneous cell population that includes immature myeloid cells and the progenitor cells of macrophages, dendritic cells (DCs), monocytes, and neutrophils. ...As a result, th
Myeloid-derived suppressor cells (MDSCs) are a heterogeneous cell population that includes immature myeloid